In Brief: 3M/Hewlett-Packard/Cemax-Icon
This article was originally published in The Gray Sheet
Executive Summary
3M/Hewlett-Packard/Cemax-Icon: Forming alliance to develop complementary products for medical diagnostic imaging, according to a joint press release. The companies agree to "share and exchange technologies and products" in order to offer their customers a broad variety of medical imaging services. Cemax-Icon plans to concentrate on application development while 3M and Hewlett-Packard will focus on hardware, service and sales issues...
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.